866-997-4948(US-Canada Toll Free)

China Intravenous-to-Subcutaneous Drug Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 98 Pages

Notes:
Sales, means the sales volume of Intravenous-to-Subcutaneous Drug
Revenue, means the sales value of Intravenous-to-Subcutaneous Drug

This report studies Intravenous-to-Subcutaneous Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Baxter
Britannia
Capricor
CSL Behring
GlaxoSmithKline
Grifols
Ferring
Janssen

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by Application, this report focuses on consumption, market share and growth rate of Intravenous-to-Subcutaneous Drug in each application, can be divided into
Application 1
Application 2

Table of Contents

China Intravenous-to-Subcutaneous Drug Market Research Report 2017
1 Intravenous-to-Subcutaneous Drug Market Overview
1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drug
1.2 Intravenous-to-Subcutaneous Drug Segment by Type
1.2.1 China Production Market Share of Intravenous-to-Subcutaneous Drug Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Applications of Intravenous-to-Subcutaneous Drug
1.3.1 Intravenous-to-Subcutaneous Drug Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 China Market Size (Value) of Intravenous-to-Subcutaneous Drug (2012-2022)
1.5 China Intravenous-to-Subcutaneous Drug Status and Outlook
1.6 Government Policies

2 China Intravenous-to-Subcutaneous Drug Market Competition by Manufacturers
2.1 China Intravenous-to-Subcutaneous Drug Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Intravenous-to-Subcutaneous Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Intravenous-to-Subcutaneous Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Intravenous-to-Subcutaneous Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravenous-to-Subcutaneous Drug Market Competitive Situation and Trends
2.5.1 Intravenous-to-Subcutaneous Drug Market Concentration Rate
2.5.2 Intravenous-to-Subcutaneous Drug Market Share of Top 3 and Top 5 Manufacturers

3 China Intravenous-to-Subcutaneous Drug Manufacturers Profiles/Analysis
3.1 Baxter
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Baxter Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Britannia
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Britannia Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Capricor
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Capricor Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 CSL Behring
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 CSL Behring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 GlaxoSmithKline
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 GlaxoSmithKline Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Grifols
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Grifols Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Ferring
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Ferring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Janssen
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Janssen Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview

4 China Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Intravenous-to-Subcutaneous Drug Capacity, Production and Growth (2012-2017)
4.2 China Intravenous-to-Subcutaneous Drug Revenue and Growth (2012-2017)
4.3 China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)

5 China Intravenous-to-Subcutaneous Drug Production, Revenue (Value), Price Trend by Type
5.1 China Intravenous-to-Subcutaneous Drug Production and Market Share by Type (2012-2017)
5.2 China Intravenous-to-Subcutaneous Drug Revenue and Market Share by Type (2012-2017)
5.3 China Intravenous-to-Subcutaneous Drug Price by Type (2012-2017)
5.4 China Intravenous-to-Subcutaneous Drug Production Growth by Type (2012-2017)

6 China Intravenous-to-Subcutaneous Drug Market Analysis by Application
6.1 China Intravenous-to-Subcutaneous Drug Consumption and Market Share by Application (2012-2017)
6.2 China Intravenous-to-Subcutaneous Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaIntravenous-to-Subcutaneous Drug Market Analysis by Regions (Provinces)
7.1 China Intravenous-to-Subcutaneous Drug Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Intravenous-to-Subcutaneous Drug Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Intravenous-to-Subcutaneous Drug Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Intravenous-to-Subcutaneous Drug Sales Price by Regions (Provinces)(2012-2017)
7.2 China Intravenous-to-Subcutaneous Drug Consumption by Regions (Provinces)(2012-2017)
7.3 China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)

8 Intravenous-to-Subcutaneous Drug Manufacturing Cost Analysis
8.1 Intravenous-to-Subcutaneous Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Intravenous-to-Subcutaneous Drug Market Forecast (2017-2022)
12.1 China Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Intravenous-to-Subcutaneous Drug Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Intravenous-to-Subcutaneous Drug Production Forecast by Type (2017-2022)
12.4 China Intravenous-to-Subcutaneous Drug Consumption Forecast by Application (2017-2022)
12.5 China Intravenous-to-Subcutaneous Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Intravenous-to-Subcutaneous Drug Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Intravenous-to-Subcutaneous Drug Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Intravenous-to-Subcutaneous Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Intravenous-to-Subcutaneous Drug Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Intravenous-to-Subcutaneous Drug
Figure China Production Market Share of Intravenous-to-Subcutaneous Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Intravenous-to-Subcutaneous Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table China Intravenous-to-Subcutaneous Drug Capacity of Key Manufacturers (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drug Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Intravenous-to-Subcutaneous Drug Capacity of Key Manufacturers in 2015
Figure China Intravenous-to-Subcutaneous Drug Capacity of Key Manufacturers in 2016
Table China Intravenous-to-Subcutaneous Drug Production of Key Manufacturers (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous-to-Subcutaneous Drug Production Share by Manufacturers
Figure 2016 Intravenous-to-Subcutaneous Drug Production Share by Manufacturers
Table China Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers
Table 2016 China Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers
Table China Market Intravenous-to-Subcutaneous Drug Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Intravenous-to-Subcutaneous Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Intravenous-to-Subcutaneous Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Intravenous-to-Subcutaneous Drug Product Type
Figure Intravenous-to-Subcutaneous Drug Market Share of Top 3 Manufacturers
Figure Intravenous-to-Subcutaneous Drug Market Share of Top 5 Manufacturers
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Baxter Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Table Britannia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Britannia Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Britannia Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Table Capricor Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Capricor Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Capricor Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Behring Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Grifols Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Table Ferring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ferring Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Ferring Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Table Janssen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Intravenous-to-Subcutaneous Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Intravenous-to-Subcutaneous Drug Market Share (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Capacity, Production and Growth (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production by Type (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production Share by Type (2012-2017)
Figure Production Market Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
Figure 2015 Production Market Share of Intravenous-to-Subcutaneous Drug by Type
Table China Intravenous-to-Subcutaneous Drug Revenue by Type (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Intravenous-to-Subcutaneous Drug by Type
Table China Intravenous-to-Subcutaneous Drug Price by Type (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Production Growth by Type (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Consumption by Application (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Consumption Market Share by Application (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Consumption Market Share by Application in 2015
Table China Intravenous-to-Subcutaneous Drug Consumption Growth Rate by Application (2012-2017)
Figure China Intravenous-to-Subcutaneous Drug Consumption Growth Rate by Application (2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production by Regions (Provinces)(2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production Market Share by Regions (Provinces)(2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production Value by Regions (Provinces)(2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Intravenous-to-Subcutaneous Drug Sales Price by Regions (Provinces)(2012-2017)
Table China Intravenous-to-Subcutaneous Drug Consumption by Regions (Provinces)(2012-2017)
Table China Intravenous-to-Subcutaneous Drug Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Intravenous-to-Subcutaneous Drug Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous-to-Subcutaneous Drug
Figure Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
Figure Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
Table Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2015
Table Major Buyers of Intravenous-to-Subcutaneous Drug
Table Distributors/Traders List
Figure China Intravenous-to-Subcutaneous Drug Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Table China Intravenous-to-Subcutaneous Drug Production, Import, Export and Consumption Forecast (2017-2022)
Table China Intravenous-to-Subcutaneous Drug Production Forecast by Type (2017-2022)
Table China Intravenous-to-Subcutaneous Drug Consumption Forecast by Application (2017-2022)
Table China Intravenous-to-Subcutaneous Drug Production Forecast by Regions (Provinces)(2017-2022)
Table China Intravenous-to-Subcutaneous Drug Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Intravenous-to-Subcutaneous Drug Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *